USPTO serial 79288155
PHARMALEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 19, 2021
- Examiner
- AGREDA, SAMANTHA LEIGH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PHARMALEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark J. Liss
Mark J. Liss Leydig, Voit & Mayer, Ltd.180 N. Stetson Ave. Suite 4900Two Prudential PlazaChicago, IL 60601Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Advertising services; business management; business administration services; providing office functions | ACTIVE | — |
| 041 | Educational services, namely, conducting online exhibitions, displays and exhibits in the field of pharmacovigilance, biosimilars, medical products, medical services, clinical data review, chemistry data evaluation, scientific research, and laboratory research in the field of pharmaceuticals, medicines and medical products; educational services, namely, conducting classes, seminars, conferences, and workshops in the field of pharmacovigilance, clinical data review, chemistry data evaluation, scientific research, and laboratory research in the field of pharmaceuticals, biosimilars, medicines and medical products and distribution of training material in connection therewith; providing of training services, for others, in the field of pharmacovigilance, clinical data review, chemistry data evaluation, scientific research, and laboratory research in the field of pharmaceuticals, biosimilars, medicines and medical products; providing of employee training services, for others in the field of pharmaceutical products, biosimilars, medical products and medical services | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, new product design and scientific research in the field of pharmacovigilance, clinical data review, chemistry data evaluation; Scientific research and laboratory research, all in the field of pharmaceuticals, medicines and medical products; industrial analysis and research services, namely, laboratory research services relating to pharmaceuticals, pharmaceutical research services, and research and development of new products for others | ACTIVE | — |
| 044 | Medical services; veterinary services | ACTIVE | — |
| 045 | Legal services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PharmaLex GmbH
- Other trademarks owned by PharmaLex GmbH
- Other trademarks owned by PharmaLex GmbH
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named PHARMALEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 15, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 18, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 17, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 30, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 30, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 19, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 19, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 3, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 3, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 1, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 14, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 14, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 14, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 25, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 25, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 25, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 25, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 25, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 26, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 26, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 26, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 5, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 28, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 21, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 20, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 17, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 30, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 26, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 25, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |